Income Statement Immix Biopharma, Inc.

Stocks

IMMX

US45258H1068

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 09:53:57 11/06/2026 pm IST			5-day change	1st Jan Change
8.125 ^USD	-0.67%		-2.02%	+57.74%

21/05	Immix Biopharma Prices $150 Million Stock Offering	MT
21/05	Immix Biopharma announces pricing of $150 million underwritten offering of common stock	RE

d80289570.KL5NRvtXPvFFGj3Ie17zhQ0PyI3cTXiflMQuyeZSyJo.RuR_MrYAVr0BLWz7DDHG7lpOhMKLPDnezYBks5QHmOsa03VzrWRywXNfdA

Published financial data: IMMIX BIOPHARMA, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Selling General & Admin Expenses, Total	12.25L	40.23L	74.06L	1.14Cr	1.37Cr
R&D Expenses	1L	41.96L	87.35L	1.13Cr	1.63Cr
Other Operating Expenses, Total	13.52L	82.19L	1.61Cr	2.27Cr	3Cr
Operating Income	-13.52L	-82.19L	-1.61Cr	-2.27Cr	-3Cr
Interest Expense, Total	-2L	-497	-	-	-
Interest And Investment Income	-	-	6L	10.17L	6L
Net Interest Expenses	-2L	-497	6L	10.17L	6L
Other Non Operating Income (Expenses)	-2.28Cr	-	-	-	-
EBT, Excl. Unusual Items	-2.43Cr	-82.19L	-1.56Cr	-2.17Cr	-2.94Cr
Other Unusual Items	-86.17T	-	-	-	-
EBT, Incl. Unusual Items	-2.44Cr	-82.19L	-1.56Cr	-2.17Cr	-2.94Cr
Income Tax Expense	6.01T	10.27T	26.42T	41.04T	37.72T
Earnings From Continuing Operations	-2.44Cr	-82.3L	-1.56Cr	-2.17Cr	-2.94Cr
Net Income to Company	-2.44Cr	-82.3L	-1.56Cr	-2.17Cr	-2.94Cr
Minority Interest	-	-	2L	84.99T	-
Net Income - (IS)	-2.44Cr	-82.3L	-1.54Cr	-2.16Cr	-2.94Cr
Net Income to Common Incl Extra Items	-2.44Cr	-82.3L	-1.54Cr	-2.16Cr	-2.94Cr
Net Income to Common Excl. Extra Items	-2.44Cr	-82.3L	-1.54Cr	-2.16Cr	-2.94Cr
Per Share Items
Net EPS - Basic	-6.64	-0.59	-0.89	-0.76	-0.89
Basic EPS - Continuing Operations	-6.64	-0.59	-0.89	-0.76	-0.89
Basic Weighted Average Shares Outstanding	36.73L	1.39Cr	1.73Cr	2.83Cr	3.3Cr
Net EPS - Diluted	-6.64	-0.59	-0.89	-0.76	-0.89
Diluted EPS - Continuing Operations	-6.64	-0.59	-0.89	-0.76	-0.89
Diluted Weighted Average Shares Outstanding	36.73L	1.39Cr	1.73Cr	2.83Cr	3.3Cr
Normalized Basic EPS	-4.13	-0.37	-0.55	-0.48	-0.56
Normalized Diluted EPS	-4.13	-0.37	-0.55	-0.48	-0.56
Supplemental Items
EBITDA	-13.5L	-82.17L	-1.61Cr	-2.26Cr	-2.97Cr
EBITA	-13.52L	-82.19L	-1.61Cr	-2.27Cr	-3Cr
EBIT	-13.52L	-82.19L	-1.61Cr	-2.27Cr	-3Cr
EBITDAR	-	-	-	-2.24Cr	-2.94Cr
Effective Tax Rate - (Ratio)	-0.02	-0.12	-0.17	-0.19	-0.13
Normalized Net Income	-1.52Cr	-51.37L	-95.61L	-1.35Cr	-1.84Cr
Interest on Long-Term Debt	1L	497	-	-	-
Supplemental Operating Expense Items
General and Administrative Expenses	12.25L	40.23L	74.06L	1.12Cr	1.34Cr
Research And Development Expense From Footnotes	1L	41.96L	87.35L	1.13Cr	1.63Cr
Net Rental Expense, Total	-	-	-	2L	3L
Stock-Based Comp., G&A Exp. (Total)	-	5L	25.66L	18.43L	19.33L
Stock-Based Comp., Other (Total)	2L	1L	-	11.78L	5L
Total Stock-Based Compensation	2L	6L	25.66L	30.21L	24.42L

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	1.76Cr	1.34Cr	1.75Cr	1.77Cr	9.39Cr
Short Term Investments	-	-	-	-	64.81L
Total Cash And Short Term Investments	1.76Cr	1.34Cr	1.75Cr	1.77Cr	10Cr
Other Receivables	25.72T	3L	11.72L	19.74L	-
Total Receivables	25.72T	3L	11.72L	19.74L	-
Prepaid Expenses	5L	12.05L	10.61L	5L	7L
Other Current Assets, Total	-	-	44.58T	32.27T	2L
Total Current Assets	1.82Cr	1.49Cr	1.98Cr	2.02Cr	10Cr
Gross Property Plant And Equipment	-	-	-	27.77L	37.82L
Accumulated Depreciation	-	-	-	-47.26T	-3L
Net Property Plant And Equipment	5.7T	3.56T	50.18T	27.3L	34.89L
Deferred Charges Long-Term	-	-	87.23T	-	93.63T
Other Long-Term Assets, Total	-	6.72T	-	20.42T	20.42T
Total Assets	1.82Cr	1.49Cr	1.99Cr	2.29Cr	10Cr
Liabilities
Accounts Payable, Total	1L	12.73L	14.33L	53.88L	54.43L
Accrued Expenses, Total	9.1T	-	22.89L	32.33L	45.28L
Short-term Borrowings	50T	-	-	-	-
Current Portion of Leases	-	-	-	65.22T	1L
Other Current Liabilities	-	-	-	-	-
Total Current Liabilities	2L	12.73L	37.22L	86.87L	1.01Cr
Long-Term Leases	-	-	-	10.1L	9L
Other Non Current Liabilities	-	5L	-	-	-
Total Liabilities	2L	17.48L	37.22L	96.97L	1.1Cr
Common Stock, Total	1.32T	1.4T	2T	2.76T	5.3T
Additional Paid In Capital	4.76Cr	5.12Cr	6.98Cr	8.84Cr	20Cr
Retained Earnings	-2.98Cr	-3.8Cr	-5.34Cr	-7.5Cr	-10Cr
Treasury Stock	-	-99.96T	-99.96T	-99.96T	-99.96T
Comprehensive Income and Other	1L	87.02T	1L	-1.06T	60.16T
Total Common Equity	1.8Cr	1.32Cr	1.64Cr	1.33Cr	9.38Cr
Minority Interest	-	-	-2L	-	-
Total Equity	1.8Cr	1.32Cr	1.62Cr	1.33Cr	9.38Cr
Total Liabilities And Equity	1.82Cr	1.49Cr	1.99Cr	2.29Cr	10Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.39Cr	1.39Cr	2.64Cr	2.77Cr	5.3Cr
ECS Total Common Shares Outstanding	1.32Cr	1.39Cr	1.99Cr	2.75Cr	5.3Cr
Book Value / Share	1.36	0.95	0.82	0.48	1.77
Tangible Book Value	1.8Cr	1.32Cr	1.64Cr	1.33Cr	9.38Cr
Tangible Book Value Per Share	1.36	0.95	0.82	0.48	1.77
Total Debt	50T	0	0	10.75L	10.73L
Net Debt	-1.76Cr	-1.34Cr	-1.75Cr	-1.66Cr	-9.93Cr
Debt Equivalent Oper. Leases	-	-	-	18.02L	21.07L
Minority Interest, Total (Incl. Fin. Div)	-	-	-2L	-	-
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	-	-	-	8L	15.7L
Full Time Employees	2	9	14	18	21
Part Time Employees	-	2	3	3	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-2.44Cr	-82.3L	-1.54Cr	-2.16Cr	-2.94Cr
Depreciation & Amortization - CF	2.47T	2.14T	5.47T	1L	4L
Depreciation & Amortization, Total	2.47T	2.14T	5.47T	1L	4L
Amortization of Deferred Charges, Total - (CF)	58.16T	-	-	-	-
Stock-Based Compensation (CF)	2L	6L	25.66L	30.21L	24.42L
Other Operating Activities, Total	2.29Cr	-	-2L	-84.99T	-
Change In Accounts Payable	-1L	11.32L	24.34L	44.02L	10.27L
Change In Income Taxes	97.67T	-2L	-9L	-10L	20.6L
Change in Other Net Operating Assets	-4L	-7L	1L	5L	-4L
Cash from Operations	-15.89L	-74.08L	-1.14Cr	-1.46Cr	-2.39Cr
Capital Expenditure	-802	-	-52.09T	-11.78L	-7L
Investment in Marketable and Equity Securities, Total	-	-	-	-	-64.81L
Cash from Investing	-802	-	-52.09T	-11.78L	-72.14L
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	2L	-	-	-	-
Total Debt Issued	2L	-	-	-	-
Short Term Debt Repaid, Total	-	-50T	-	-	-
Total Debt Repaid	-	-50T	-	-	-
Issuance of Common Stock	1.86Cr	29.14L	1.55Cr	1.59Cr	11Cr
Repurchase of Common Stock	-	-99.96T	-	-	-
Other Financing Activities, Total	-	5L	-59.62T	-	-1L
Cash from Financing	1.88Cr	32.32L	1.55Cr	1.59Cr	11Cr
Foreign Exchange Rate Adjustments	-5.43T	-31.52T	33.09T	-3.62T	3.84T
Miscellaneous Cash Flow Adjustments	-	-	-	10	-
Net Change in Cash	1.73Cr	-42.08L	40.73L	2L	7.62Cr
Supplemental Items
Cash Interest Paid	1.54T	9.6T	-	-	-
Cash Income Tax Paid (Refund)	-	-	-	-	-
Levered Free Cash Flow	-20.98L	-43.09L	-59.37L	-75.51L	-1.36Cr
Unlevered Free Cash Flow	-20.43L	-43.09L	-59.37L	-75.51L	-1.36Cr
Change In Net Working Capital	14.19L	-2L	-16.32L	-46.62L	-30.37L
Net Debt Issued / Repaid	2L	-50T	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-9.02	-31.04	-57.92	-66.11	-29.3
Return on Total Capital	-9.71	-32.93	-68.71	-92.84	-34.29
Return On Equity %	-367.8	-52.84	-106.22	-147.33	-55
Return on Common Equity	-367.8	-52.84	-104.35	-145.76	-55
Short Term Liquidity
Current Ratio	90.01	11.7	5.32	2.33	10.01
Quick Ratio	87.46	10.75	5.02	2.26	9.93
Operating Cash Flow to Current Liabilities	-7.87	-5.82	-3.06	-1.68	-2.37
Long Term Solvency
Total Debt/Equity	0.28	-	-	8.11	1.14
Total Debt / Total Capital	0.28	-	-	7.5	1.13
LT Debt/Equity	-	-	-	7.62	1
Long-Term Debt / Total Capital	-	-	-	7.05	0.98
Total Liabilities / Total Assets	1.11	11.73	18.68	42.26	10.53
EBIT / Interest Expense	-7.52	-16.54T	-	-	-
EBITDA / Interest Expense	-7.5	-16.53T	-	-	-
(EBITDA - Capex) / Interest Expense	-7.51	-16.53T	-	-	-
Total Debt / EBITDA	-0.04	-	-	-0.05	-0.04
Net Debt / EBITDA	13.04	1.64	1.09	0.74	3.37
Total Debt / (EBITDA - Capex)	-0.04	-	-	-0.05	-0.04
Net Debt / (EBITDA - Capex)	13.03	1.64	1.08	0.7	3.29
Growth Over Prior Year
EBITDA, 1 Yr. Growth %	198.88	508.86	96.37	40.32	31.22
EBITA, 1 Yr. Growth %	197.9	507.9	96.39	40.48	32.11
EBIT, 1 Yr. Growth %	197.9	507.9	96.39	40.48	32.11
Earnings From Cont. Operations, 1 Yr. Growth %	2.02T	-66.25	89.5	39.13	35.67
Net Income, 1 Yr. Growth %	2.02T	-66.25	87.44	40.11	36.21
Normalized Net Income, 1 Yr. Growth %	2.05T	-66.16	86.12	40.68	36.61
Diluted EPS Before Extra, 1 Yr. Growth %	1.85T	-91.07	50.11	-14.1	16.87
Net Property, Plant and Equip., 1 Yr. Growth %	-22.63	-37.49	1.31T	5.34T	27.8
Total Assets, 1 Yr. Growth %	3.27T	-18.05	33.65	15.17	356.86
Tangible Book Value, 1 Yr. Growth %	-480.29	-26.85	24.66	-19.23	607.83
Common Equity, 1 Yr. Growth %	-480.29	-26.85	24.66	-19.23	607.83
Cash From Operations, 1 Yr. Growth %	292.72	366.13	53.5	28.35	63.96
Capital Expenditures, 1 Yr. Growth %	-	-	-	2.16T	-37.77
Levered Free Cash Flow, 1 Yr. Growth %	-632.49	105.43	37.8	27.18	80.27
Unlevered Free Cash Flow, 1 Yr. Growth %	-546.48	110.87	37.81	27.18	80.27
Compound Annual Growth Rate Over Two Years
EBITDA, 2 Yr. CAGR %	26.64	326.59	245.78	66	35.69
EBITA, 2 Yr. CAGR %	26.68	325.55	245.52	66.1	36.23
EBIT, 2 Yr. CAGR %	26.68	325.55	245.52	66.1	36.23
Earnings From Cont. Operations, 2 Yr. CAGR %	400.65	167.76	-20.03	62.38	37.39
Net Income, 2 Yr. CAGR %	400.65	167.76	-20.46	62.06	38.14
Normalized Net Income, 2 Yr. CAGR %	405.07	169.66	-20.64	61.81	38.63
Diluted EPS Before Extra, 2 Yr. CAGR %	379.94	32	-63.4	13.55	0.19
Net Property, Plant and Equip., 2 Yr. CAGR %	-23.31	-30.46	196.84	2.67T	733.78
Total Assets, 2 Yr. CAGR %	339.24	425.63	4.65	24.07	129.38
Tangible Book Value, 2 Yr. CAGR %	122.12	66.79	-4.51	0.35	139.11
Common Equity, 2 Yr. CAGR %	122.12	66.79	-4.51	0.35	139.11
Cash From Operations, 2 Yr. CAGR %	41.83	327.85	167.49	40.36	45.07
Capital Expenditures, 2 Yr. CAGR %	-66.87	-	705.91	-	275.11
Levered Free Cash Flow, 2 Yr. CAGR %	-	230.74	68.25	32.38	51.41
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	206.83	70.47	32.39	51.41
Compound Annual Growth Rate Over Three Years
EBITDA, 3 Yr. CAGR %	-	113.75	229.38	156	53.49
EBITA, 3 Yr. CAGR %	-	113.67	228.86	155.97	53.9
EBIT, 3 Yr. CAGR %	-	113.67	228.86	155.97	53.9
Earnings From Cont. Operations, 3 Yr. CAGR %	-	103.76	138.62	-3.81	52.94
Net Income, 3 Yr. CAGR %	-	103.76	137.75	-3.94	52.94
Normalized Net Income, 3 Yr. CAGR %	-	105.13	138.31	-3.96	52.93
Diluted EPS Before Extra, 3 Yr. CAGR %	-	27.16	37.78	-51.36	14.65
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-28.36	89.61	682.59	893.26
Total Assets, 3 Yr. CAGR %	-	150.98	233	8.05	91.59
Tangible Book Value, 3 Yr. CAGR %	-	53.39	51.36	-9.69	92.45
Common Equity, 3 Yr. CAGR %	-	53.39	51.36	-9.69	92.45
Cash From Operations, 3 Yr. CAGR %	-	110.87	204.02	109.41	47.82
Capital Expenditures, 3 Yr. CAGR %	-	-	-	1.04T	-
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	147.02	53.26	46.73
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	134.98	54.61	46.74
Compound Annual Growth Rate Over Five Years
EBITDA, 5 Yr. CAGR %	-	-	-	93.19	131.02
EBITA, 5 Yr. CAGR %	-	-	-	93.19	131.16
EBIT, 5 Yr. CAGR %	-	-	-	93.19	131.16
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	86.07	91.34
Net Income, 5 Yr. CAGR %	-	-	-	85.93	91.34
Normalized Net Income, 5 Yr. CAGR %	-	-	-	86.56	91.88
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	21.53	21.3
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	209.05	242.88
Total Assets, 5 Yr. CAGR %	-	-	-	89.34	186.87
Tangible Book Value, 5 Yr. CAGR %	-	-	-	29.44	81.74
Common Equity, 5 Yr. CAGR %	-	-	-	29.44	81.74
Cash From Operations, 5 Yr. CAGR %	-	-	-	79.19	126.13
Capital Expenditures, 5 Yr. CAGR %	-	-	-	176.34	-
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	103.1
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	97.1